Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zegami is a data visualization and analysis company that spun out of the University of Oxford to address the challenges of managing large, complex image datasets in scientific research. The company's platform utilizes machine learning and intuitive graphical interfaces to enable users to explore, categorize, and analyze thousands of images and data points simultaneously. In the healthcare sector, Zegami has been utilized for medical imaging, clinical trial data exploration, and identifying diagnostic markers in diseases such as cancer and COVID-19. The technology is designed to bridge the gap between raw data and actionable insights by making large-scale data more accessible to non-technical experts. In July 2023, Zegami was acquired by Vero AI, a company focused on AI auditing and transparency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zegami.